BCM
CLYM
BML Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,193,742
| Closed | -$6.01M | – | 33 |
|
|
2024
Q1 | $6.01M | Buy |
2,193,742
+13,742
| +0.6% | +$37.7K | 3.96% | 7 |
|
|
2023
Q4 | $5.89M | Buy |
2,180,000
+241,737
| +12% | +$653K | 4.46% | 6 |
|
|
2023
Q3 | $5.1M | Buy |
1,938,263
+355,093
| +22% | +$934K | 4.68% | 8 |
|
|
2023
Q2 | $4.43M | Sell |
1,583,170
-75,000
| -5% | -$210K | 3.99% | 9 |
|
|
2023
Q1 | $4.81M | Sell |
1,658,170
-166,964
| -9% | -$484K | 4.16% | 8 |
|
|
2022
Q4 | $6.7M | Buy |
+1,825,134
| New | +$6.7M | 6.4% | 7 |
|